News & Media
March 25, 2024
Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency
COLUMBUS, OH, March 25, 2024 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...
February 28, 2024
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)
COLUMBUS, OH, February 28, 2024 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...
January 15, 2024
Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A (CMT1A)
COLUMBUS, OH, January 15, 2024 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...
December 18, 2023
Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome
Columbus, OH, December 18, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...
November 20, 2023
Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)
COLUMBUS, OH, Nov 20, 2023 – Battelle, Andelyn Biosciences, Inc., and AmplifyBio, have been awarded a new task order from the...
November 9, 2023
Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies
COLUMBUS, OH, Nov 9, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...
October 20, 2023
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases
COLUMBUS, OH, OCTOBER 20, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...